Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

被引:19
|
作者
Stavropoulos, Konstantinos [1 ]
Imprialos, Konstantinos [1 ]
Pittaras, Andreas [2 ,3 ]
Faselis, Charles [2 ,3 ]
Narayan, Puneet [2 ,3 ]
Kokkinos, Peter [2 ,3 ]
机构
[1] Aristotle Univ Thessaloniki, Propaedeut Dept Med 2, Thessaloniki, Greece
[2] VAMC, Washington, DC USA
[3] Georgetown Univ, Sch Med, Washington, DC 20057 USA
关键词
Non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; lifestyle modification; weight loss; physical activity; nutrition; diet; CORONARY-HEART-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; BODY-MASS INDEX; PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; EXERCISE CAPACITY; WEIGHT-LOSS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; RISK-FACTORS;
D O I
10.2174/1570161115666170621080835
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is one of the most common diseases worldwide, affecting more than 30% of general population. High-fat diets, physical inactivity and obesity, all prevalent in the western societies, are strongly associated with the development and progression of NAFLD. Current drug therapies have not consistently shown substantial beneficial effects. Thus, lifestyle modification appears to be the optimal intervention in combating the disease. Accordingly, several studies have concluded that weight loss, via increase in physical activity, and dietary interventions could potential ameliorate biochemical, histological, and structural abnormalities of non-alcoholic fatty liver disease. The aim of this review is to summarize the findings of these lifestyle intervention studies and discuss the implementation of each intervention, and its effectiveness in the management of the disease in everyday clinical practice.
引用
收藏
页码:239 / 245
页数:7
相关论文
共 50 条
  • [31] Fecal Microbiota in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review
    Mohammadi, Zahra
    Poustchi, Hossein
    Motamed-Gorji, Nazgol
    Eghtesad, Sareh
    Hekmatdoost, Azita
    Saniee, Parastoo
    Merat, Shahin
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2020, 23 (01) : 44 - 52
  • [32] Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Dowman, J. K.
    Tomlinson, J. W.
    Newsome, P. N.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (05) : 525 - 540
  • [33] Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis
    Lirussi, F.
    Mastropaqua, E.
    Orando, S.
    Orlando, R.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [34] Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis
    Le, Thuy-Anh
    Loomba, Rohit
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2012, 2 (02) : 156 - 173
  • [35] THE PATHOLOGICAL PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE CORRELATES WITH GUT MICROBIOTA COMPOSITION IN MICE: FROM NON-ALCOHOLIC FATTY LIVER TO NON-ALCOHOLIC STEATOHEPATITIS
    Peng, J.
    Huang, F.
    Li, X.
    Chen, L.
    Feng, Q.
    Hu, Y.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S155 - S157
  • [36] Clinical Predictors of Recurrent Non-Alcoholic Steatohepatitis Following Liver Transplantation for Non-Alcoholic Fatty Liver Disease
    Stein, L.
    Dunn, W.
    Nguyen, H.
    Bhasin, D.
    Pollinger, H.
    Johnson, M.
    Shrestha, R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 703 - 703
  • [37] Lifestyle advice in non-alcoholic fatty liver disease
    Manco, Melania
    Marcellini, Matilde
    Nobili, Valerio
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (04) : 604 - 605
  • [38] Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Non-invasive tests are enough
    Castera, Laurent
    [J]. LIVER INTERNATIONAL, 2018, 38 : 67 - 70
  • [39] Lifestyle interventions for non-alcoholic fatty liver disease
    Ahmed, Idris Adewale
    Mikail, Maryam Abimbola
    Mustafa, Mohammad Rais
    Ibrahim, Muhammad
    Othman, Rozana
    [J]. SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2019, 26 (07) : 1519 - 1524
  • [40] Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Sachiko Hattori
    Kazuomi Nomoto
    Tomohiko Suzuki
    Seishu Hayashi
    [J]. Diabetology & Metabolic Syndrome, 13